ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2670

Comparison of M-DAS and DAS28, Two Composite Scores for Prediction of Structural Damages in Rheumatoid Arthritis: Data from the Espoir Cohort

Marion Couderc1, Bruno Pereira2, B G Combe3, Valerie Devauchelle4, Xavier Mariette5 and Martin Soubrier1, 1Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, 2Biostatistics unit (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France, 3Hospital Lapeyronie, Immuno-Rheumatology, Montpellier, France, 4Service de Rhumatologie, CHU Brest, Brest, France, 5Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Numbers of composite scores are available to assess disease activity in rheumatoid arthritis (RA), the most widely used being the Disease-Activity-Score in 28 joints (DAS28), the Simplified-Disease-Activity-Index (SDAI), and the Clinical-Disease-Activity-Score (CDAI). Baker et al. have recently developed a modified version of these scores (M-DAS28, M-CDAI, M-SDAI) based on widely available clinical measures (swollen joint count [SJC] evaluator global assessment of disease activity [EvGA] and CRP level). (1) These scores demonstrated superior correlation with MRI detection of synovitis and more accurately predicted radiographic progression after 1 year than DAS28 and SDAI.The objective of the study was to evaluate the performance of new composite disease activity scores (M-DAS28, M-SDAI and M-CDAI]) compared to conventional measures (DAS28, SDAI and CDAI) to predict radiographic progression in rheumatoid arthritis patients from the ESPOIR cohort.

Methods: The French multicentric ESPOIR cohort included a total of 664 patients with early (< 6 months) unclassified arthritis. This study was conducted on the patients fulfilling the ACR/EULAR 2010 classification criteria for RA. The M-DAS28, M-SDAI, and M-CDAI were respectively compared to the DAS28, CDAI and SDAI for predicting radiographic progression (estimated after 1 year by The Sharp/van der Heidje [SHS] scoring system).

Results: A total of 590 RA patients (women 78%, age 48.8 years, symptoms duration 16 weeks, SJC 8, tender joint count 9, ESR 29 mm at the first hour, CRP level 22 mg/L, DAS28-ESR 5.2, DAS28-CRP 5.0, SDAI 30.4, CDAI 28.3) were included.

Ability to predict radiographic progression after 1 year was the same between baseline M-DAS28-ESR and DAS28-ESR (Area under the curve [AUC]: 0.53 [0.49–0.58] vs 0.53 [0.48–0.58] respectively), M-DAS28-CRP and DAS28-CRP (AUC : 0.54 [0.49–0.59] vs 0.52 [0.47–0.57] respectively), M-SDAI and SDAI (AUC : 0.52 [0.47–0.57] vs 0.51 [0.46–0.56] respectively), M-CDAI and CDAI (AUC: 0.51 [0.47–0.56] vs. 0.50 [0.45–0.55] respectively).

Conclusion: In conclusion, modified disease activity scores (M-DAS28-ESR, M-DAS28-CRP, M-CDAI and M-SDAI), based on clinical measures of disease activity, did not prove superiority to original disease activity scores on ability to predict structural progression in patients with RA.

Reference :

1 – Baker JF, Conaghan PG, Smolen JS, Aletaha D, Shults J, Emery P, et al. Development and validation of modified disease activity scores in rheumatoid arthritis: Superior correlation with MRI synovitis and X-ray progression. Arthritis Rheum. 2014;66:794-802


Disclosure: M. Couderc, None; B. Pereira, None; B. G. Combe, None; V. Devauchelle, None; X. Mariette, None; M. Soubrier, None.

To cite this abstract in AMA style:

Couderc M, Pereira B, Combe BG, Devauchelle V, Mariette X, Soubrier M. Comparison of M-DAS and DAS28, Two Composite Scores for Prediction of Structural Damages in Rheumatoid Arthritis: Data from the Espoir Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/comparison-of-m-das-and-das28-two-composite-scores-for-prediction-of-structural-damages-in-rheumatoid-arthritis-data-from-the-espoir-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-m-das-and-das28-two-composite-scores-for-prediction-of-structural-damages-in-rheumatoid-arthritis-data-from-the-espoir-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology